FDA Gives Emergency Authorization of Hydroxychloroquine Use

The Food And Drug Administration (FDA) issued an emergency authorization Sunday for hydroxychloroquine, a drug already used to treat malaria and other ailments, which has shown anecdotal efficacy against coronavirus.

The use of the drug — often paired with azithromycin — has not yet been proven in clinical trials to be effective against the disease. However, given reported success in a growing number of small, non-randomized studies; as well as testimonials from doctors and patients about the use of the “off-label” drug regimen, doctors are said to be prescribing the treatment to patients who are severely ill. Anecdotally, many doctors are taking it prophylactically.

The Department of Health and Human Services (HHS) issued a statement on Sunday:

The U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) to BARDA to allow hydroxychloroquine sulfate and chloroquine phosphate products donated to the Strategic National Stockpile (SNS) to be distributed and prescribed by doctors to hospitalized teen and adult patients with COVID-19, as appropriate, when a clinical trial is not available or feasible.

CIA’s Counter Espionage Department Investigated Unvaccinated Employees, Lawsuit Alleges

Florida Attorney General Calls to Impeach Judge Who Acquitted Murderous Mother

Platner aide hit with brutal timeline check after campaign denied rape claim, then folded days later

EXCLUSIVE: Former ‘Apprentice’ star picked by Trump to showcase America’s 250th anniversary through art

The RNC wants a massive Trump celebration. Some worry ordinary Republicans can’t afford to attend

BREAKING: GOP Sen. Lindsey Graham Dead at 71

Sen. Lindsey Graham dead at 71 after ‘brief and sudden’ illness, office says

Fox News Campus Radicals Newsletter: Alleged K-12 fraud, one school’s battle with Newsom and a win in Florida

‘Die Hard’ actor Robert Davi blasts Mamdani after NYC map omits Little Italy

Dem governor escalates McConnell health demands, cites response to past Trump health concerns

Another US citizen tests positive for Ebola virus while working in Congo amid record outbreak

Sanders and Ocasio-Cortez to stump for Abdul el Sayed in Michigan Senate primary

Army Black Hawks airlift 200-plus stranded campers as Missouri floods trigger more 350 rescues

Renowned Feminist Historian Loses Professorship as Experts Tear Apart Her So-Called Historical Findings

NYPD officer charged with rape, child sex crimes previously admitted to misconduct on the job, records show

HHS also noted that it had “accepted 30 million doses of hydroxychloroquine sulfate donated by Sandoz, the Novartis generics and biosimilars division, and one million doses of chloroquine phosphate donated by Bayer Pharmaceuticals, for possible use in treating patients hospitalized with COVID-19 or for use in clinical trials.”

Earlier, the French government had approved similar drugs to treat the virus.

Amid concerns that the sudden interest in hydroxychloroquine could cause shortages, HHS noted: “Use of the donated medications is expected to help ease supply pressures for the drug, and the FDA is also working with manufacturers of chloroquine and hydroxychloroquine to increase production to ensure these drugs also remain available for patients dependent on them for treatment of malaria, lupus and rheumatoid arthritis.”